Reactions to low rates of molecular testing for patients with non-small cell lung cancer in community settings. Charu Aggarwal, M.D., MPH: Recent data show that there are many challenges. We saw ...

Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...

When the Insurance Institute for Highway Safety’s “SORB,” the Small Overlap Rigid Barrier test, launched in 2012, many automakers were caught flat-footed, with vehicles that had been Top Safety Picks ...

Biomarker testing has become increasingly important for making informed, personalized treatment decisions for patients with cancer. However, a new nationwide survey conducted by the American Cancer ...

Please provide your email address to receive an email when new articles are posted on . Nearly all individuals who self-navigated the entire online platform completed germline testing. The platform ...